Thermo Fisher Scientific Opens U.S. Precision Medicine Science Center

Thermo Fisher Scientific Opens U.S. Precision Medicine Science Center Supports development of analytical workflows to generate precise molecular profiles of patients BOSTON and SAN DIEGO, June 4, 2018 /PRNewswire/ — BIO 2018 and ASMS 2018 — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today officially opened its U.S. Precision Medicine Science Center (PMSC)... Read more

SCIEX Announces Latest Innovations for Improving Healthcare and Well-being at ASMS

FRAMINGHAM, MASS – 04 June 2018 – SCIEX, a global leader in life science analytical technologies, has announced today that it will highlight a suite of recent innovations for streamlining biotherapeutics research and development, as well as its latest technologies for delivering accessible, high performance clinical diagnostics, at ASMS 2018. These developments have been optimized... Read more

BD, Helmer Scientific Collaborate to Introduce First Fully Integrated Refrigerated Automated Dispensing Solution

DENVER, June 4, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Helmer Scientific, a leading provider of integrated solutions to safeguard temperature-sensitive medications, today announced a collaboration to introduce an industry-first, medical-grade refrigerated solution integrated with an automated dispensing system to provide clinicians secure, single line-item access... Read more

Roche presents new data across a range of blood cancers at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

Basel, 03 June 2018 Roche presents new data across a range of blood cancers at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting Further data demonstrate polatuzumab vedotin’s clinical efficacy across a range of diffuse large B-cell lymphoma subgroups Additional results from the randomised phase III MURANO study support fixed-duration Venclexta/Venclyxto plus MabThera/Rituxan... Read more

International Childhood Oncology Network to Host Inaugural Meeting at Annual ASCO Conference

International Childhood Oncology Network to Host Inaugural Meeting at Annual ASCO Conference Network of academic and clinical researchers converge to advance pediatric cancer research CARLSBAD, Calif., June 1, 2018 /PRNewswire/ — The International Childhood Oncology Network (ICON) will host its inaugural meeting at the annual American Society of Clinical Oncology (ASCO) conference in Chicago June... Read more

GE Healthcare Introduces Virtual Reality Training for Healthcare Technology Management Professionals

Milwaukee, Wis – June 1, 2018 – With 25 percent of the Healthcare Technology Management (HTM) population expected to retire over the next 10 years, hospitals and healthcare systems face an increasing challenge to train the next generation of professionals safely, affordably and efficiently. At AAMI 2018, GE Healthcare is introducing interactive, customizable training options... Read more

Roche to present data for TECENTRIQ (atezolizumab) from across its genitourinary and gastrointestinal cancer immunotherapy programme at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

Basel, 01 June 2018 Roche to present data for TECENTRIQ (atezolizumab) from across its genitourinary and gastrointestinal cancer immunotherapy programme at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting The data to be presented further demonstrate potential of TECENTRIQ and Avastin combination in renal cell carcinoma, a type of kidney cancer, and hepatocellular... Read more

QIAGEN showcases innovation in NGS solutions for precision medicine at ASCO 2018

● Introduces pipeline to reach patients more quickly with next-generation sequencing for cancer, in line with modernized regulatory approach from the U.S. Food and Drug Administration ● Announces partnership with Freenome to accelerate companion diagnostics development in immuno-oncology by combining industry-leading artificial intelligence with QIAGEN’s Sample to Insight solutions ● Showcases QIAGEN’s NGS technologies, including... Read more

VWR, Part of Avantor, Named Sole Supplier for Cell and Gene Therapy Catapult

Cell and Gene Therapy Catapult contracts VWR for its laboratory consumable needs RADNOR, Pennsylvania, May 24, 2018 /PRNewswire/ — VWR, acquired by Avantor in 2017 as a wholly-owned subsidiary and a leading global provider of product and service solutions to laboratory and production customers, has been named the sole supplier of laboratory consumable products for Cell and... Read more

QIAGEN welcomes WHO’s Essential Diagnostics List which includes QuantiFERON-TB Gold

The World Health Organization recommends IGRA tests in the First Edition of Essential In Vitro Diagnostics Germantown, Maryland, and Hilden, Germany, May 22, 2018 – QIAGEN today welcomed the First Edition of the World Health Organization’s (WHO) Essential Diagnostics List, which endorses the use of interferon gamma release assays (IGRAs) for the diagnosis of latent TB... Read more